Advisory Services Network’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
ACA
SCM
Advisory Services Network's KRYS Position: Q2 2026 in Review
Advisory Services Network reduced its Krystal Biotech (KRYS) stake by 30% in Q2 2026, selling an estimated $86.9K and leaving 674 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #1851.
Advisory Services Network first reported a position in KRYS in Q4 2023 and has held it in 4 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.
- Advisory Services Network held 674 shares of Krystal Biotech worth $251K as of Q2 2026.
- Advisory Services Network sold 291 Krystal Biotech shares in Q2 2026, an estimated $86.9K.
- Krystal Biotech made up ﹤0.01% of Advisory Services Network's portfolio in Q2 2026, its #1851 holding.
- Advisory Services Network first reported a position in Krystal Biotech in Q4 2023 and has held it in 4 quarters since.
- 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.